CYCN - Cyclerion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-64.90%
S&P500 52-Week Change 310.93%
52 Week High 314.8300
52 Week Low 31.6900
50-Day Moving Average 33.7897
200-Day Moving Average 33.2094

Share Statistics

Avg Vol (3 month) 3249.19k
Avg Vol (10 day) 3168.6k
Shares Outstanding 527.75M
Float 19.42M
% Held by Insiders 112.58%
% Held by Institutions 160.42%
Shares Short (May 14, 2020) 41.17M
Short Ratio (May 14, 2020) 46.25
Short % of Float (May 14, 2020) 44.71%
Short % of Shares Outstanding (May 14, 2020) 44.21%
Shares Short (prior month Apr 14, 2020) 41.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,016.99%

Management Effectiveness

Return on Assets (ttm)-92.92%
Return on Equity (ttm)-286.92%

Income Statement

Revenue (ttm)5.52M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)4.51M
EBITDA -108.56M
Net Income Avi to Common (ttm)-105.86M
Diluted EPS (ttm)-3.8560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67.1M
Total Cash Per Share (mrq)2.42
Total Debt (mrq)49.72M
Total Debt/Equity (mrq)60.98
Current Ratio (mrq)6.13
Book Value Per Share (mrq)2.94

Cash Flow Statement

Operating Cash Flow (ttm)-97.12M
Levered Free Cash Flow (ttm)-64.4M